Bristol Myers Squibb (BMY) closed the most recent trading day at $49.33, moving -1.35% from the previous trading session. The stock's change was more than the S&P 500's daily loss of 2.24%.

Bristol Myers Squibb Co. closed 20.32% short of its 52-week high of $63.33, which the company achieved on March 11th.

PRINCETON, N.J., April 14, 2025--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY) today announced the Phase 3 ODYSSEY-HCM trial evaluating Camzyos (mavacamten) for the treatment of adult patients ...

In a report released today, Geoff Meacham from Citi maintained a Hold rating on Bristol-Myers Squibb (BMY – Research Report). The company’s ...

Bearish flow noted in Bristol Myers (BMY) Squibb with 7,624 puts trading, or 1.4x expected. Most active are 5/2 weekly 50 puts and May-25 65 calls, with total volume in those strikes near 5,500 ...

Bristol Myers Squibb pays investors a very attractive dividend that yields 4.1%. The company reported a loss last year, but that was a result of non-recurring expenses. Free cash flow looked ...

NEW YORK, April 8 (Reuters) - Bristol Myers Squibb (BMY.N), opens new tab won the dismissal of a proposed class action accusing it of fraudulently obtaining patents and filing sham patent lawsuits ...

Around the same time, the prototype of the Squibb logo was designed. The logo represented product uniformity, purity, efficacy and reliability based on research. By 1924, Bristol-Myers' gross ...